← Evidence map

ArticleTheranostics2026

CAR-T manufacturing reduces heterogeneity between CIDP and multiple myeloma patient-derived T cells.

Xu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41695471